FIELD: medicine.
SUBSTANCE: invention concerns medicine, namely, to surgical stomatology and can be used at treatment of septic wounds of maxillofacial area. For this purpose the 4.16% cycloferon immunomodulator solution, prepared by its dilution with the 0.9% sodium chloride solution is injected into an exudative phase of a septic wound process against complex medicamental treatment in a wound on turundas. In case of the expressed exudation, the cycloferon solution is diluted with the 10% sodium chloride hypertonic solution. Dressings are performed daily. In a proliferative phase of a wound process cycloferon is injected into a wound a kind of 5% liniment, thus dressings are performed in a day. The way allows raising efficiency of complex treatment of patients with the given pathology without system influence on immune system at the expense of local cycloferon immunocorrection taking into account wound process phases.
EFFECT: increase of efficiency of complex treatment of patients with the given pathology without system influence on immune system at the expense of local cycloferon immunocorrection taking into account wound process phases.
3 tbl, 3 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR LOCAL IMMUNOCORRECTION OF PURULENT WOUNDS OF ORAL AREA | 2005 |
|
RU2311174C2 |
WAY OF LOCAL IMMUNOTHERAPY OF PYOINFLAMMATORY DISEASES OF SOFT TISSUES OF MAXILLOFACIAL AREA | 2007 |
|
RU2361607C2 |
METHOD OF LOCAL IMMUNOCORRECTION OF FEMALE INFECTIOUS-INFLAMMATORY UROGENITAL DISEASES CAUSED BY SEXUALLY-TRANSMITTED MICROORGANISMS | 2009 |
|
RU2455037C2 |
METHOD FOR LOCAL IMMUNE THERAPY OF CHRONIC ODONTOGENIC MAXILLITIS | 2010 |
|
RU2460528C2 |
METHOD FOR TREATING MAXILLOFACIAL ODONTOGENOUS PHLEGMON CASES IN AGED PATIENTS | 2004 |
|
RU2271210C2 |
METHOD FOR PREDICTING WOUND DEVELOPMENT PROCESS COURSE | 1997 |
|
RU2146367C1 |
METHOD FOR TREATING PURULENT WOUNDS IN MAXILLOFACIAL REGION | 1999 |
|
RU2159086C1 |
CYCLOPHERONE-BASED PHARMACEUTICAL COMPOSITION OF LOCAL OR EXTERNAL APPLICATION FOR TREATMENT OF PURULENT-DESTRUCTIVE AFFECTION OF MUCOUS MEMBRANE AND SKIN, GENERAL-SYSTEM DISEASES IN CASE OF IMMUNODEFICIENCY CONDITIONS (VERSIONS) | 2008 |
|
RU2414221C2 |
METHOD FOR INTEGRATED TREATMENT OF MAXILLOFACIAL ABSCESSES AND PHLEGMONS IN CHILDREN BY OINTMENT WITH FURACILIN, LIDOCAINE AND DIBUNOL | 2011 |
|
RU2470629C1 |
METHOD FOR INTEGRATED TREATMENT OF MAXILLOFACIAL ABSCESSES AND PHLEGMONS IN CHILDREN BY OINTMENT WITH FURACILIN, LIDOCAINE AND DIBUNOL | 2011 |
|
RU2445075C1 |
Authors
Dates
2009-07-20—Published
2007-06-04—Filed